InvestSMART

Zelira Therapeutics Limited (ASX: ZLD) - Announcements

- Current share price for ZLD : $0.500

ASX company news and announcements for Zelira Therapeutics Limited (ZLD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Zelira Therapeutics Limited (ZLD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Zelira Therapeutics Limited (ZLD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Zelira Therapeutics Limited (ZLD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$7 Zelira and Health House execute Scheme Implementation Deed 19 Apr 2022 8:46AM $0.018 $0.500 risen by 2,677.78%
$7 HHI: Zelira and HHI execute Scheme Implementation Deed 19 Apr 2022 8:45AM $0.018 $0.500 risen by 2,677.78%
$7 Update - Consolidation/Split - ZLD 12 Apr 2022 4:31PM $0.018 $0.500 risen by 2,677.78%
$7 Results of Meeting 12 Apr 2022 12:57PM $0.019 $0.500 risen by 2,531.58%
$7 EDCDM Technology Licence Agreement Update 5 Apr 2022 3:51PM $0.020 $0.500 risen by 2,400%
$7 Consolidation/Split - ZLD 14 Mar 2022 2:35PM $0.018 $0.500 risen by 2,677.78%
$7 Notice of General Meeting/Proxy Form 11 Mar 2022 4:17PM $0.018 $0.500 risen by 2,677.78%
$7 Letter to Shareholders 11 Mar 2022 4:17PM $0.018 $0.500 risen by 2,677.78%
$7 Section 708A Cleansing Notice 28 Feb 2022 6:42PM $0.022 $0.500 risen by 2,172.73%
$7 Application for quotation of securities - ZLD 28 Feb 2022 6:38PM $0.022 $0.500 risen by 2,172.73%
$7 Ceasing to be a substantial holder 25 Feb 2022 5:20PM $0.022 $0.500 risen by 2,172.73%
$7 HHI: Zelira Therapeutics Ltd to acquire Health House 24 Feb 2022 8:08AM $0.025 $0.500 risen by 1,900%
$7 Zelira to acquire Health House International Limited 24 Feb 2022 8:08AM $0.025 $0.500 risen by 1,900%
$7 Appendix 4D & FY22 Interim Financial Report 23 Feb 2022 4:32PM $0.025 $0.500 risen by 1,900%
$7 Notification of cessation of securities - ZLD 21 Feb 2022 1:57PM $0.028 $0.500 risen by 1,685.71%
$7 Change of Director's Interest Notice x 4 4 Feb 2022 5:22PM $0.028 $0.500 risen by 1,685.71%
$7 Section 708A Cleansing Notice 3 Feb 2022 5:52PM $0.029 $0.500 risen by 1,624.14%
$7 Application for quotation of securities - ZLD 3 Feb 2022 5:51PM $0.029 $0.500 risen by 1,624.14%
$7 Final Director's Interest Notice 31 Jan 2022 5:17PM $0.028 $0.500 risen by 1,685.71%
$7 Initial Director's Interest Notice 31 Jan 2022 5:17PM $0.028 $0.500 risen by 1,685.71%
$7 Board Changes 31 Jan 2022 5:15PM $0.028 $0.500 risen by 1,685.71%
$7 Appendix 4C Cash Flow Report 31 Jan 2022 8:09AM $0.029 $0.500 risen by 1,624.14%
$7 December 2021 Quarterly Activities Report 31 Jan 2022 8:08AM $0.029 $0.500 risen by 1,624.14%
$7 Notification of cessation of securities - ZLD 20 Jan 2022 4:12PM $0.032 $0.500 risen by 1,462.50%
$7 Application for quotation of securities - ZLD 18 Jan 2022 6:23PM $0.031 $0.500 risen by 1,512.90%

176 - 200 of 546 results

Page 8 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.